SCHEMBL7024286

SCHEMBL7024286

C#Cc1cccc(Nc2ncnc3[nH]cc(C#N)c23)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.53
AURKA O14965 1/20 0.50
RPS6KB1 P23443 1/20 0.50
LRRK2 Q5S007 2/20 0.49
CHUK O15111 1/20 0.48
KDR P35968 1/20 0.47
GAK O14976 3/20 0.47
FBP1 P09467 2/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
ABCG2 Q9UNQ0 1/20 0.46
RIPK2 O43353 1/20 0.43
BUB1 O43683 1/20 0.43
STK10 O94804 1/20 0.43
CARS1 P49589 1/20 0.43
MAP3K1 Q13233 1/20 0.43
PIP4K2C Q8TBX8 1/20 0.43
SLK Q9H2G2 1/20 0.43
DYRK1A Q13627 1/20 0.43
DYRK1B Q9Y463 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7024764 0.88 AURKA (0.49) EGFRAURKARPS6KB1LRRK2KDR
SCHEMBL7016150 0.84 BRAF (0.58) EGFRAURKARPS6KB1LRRK2KDR
SCHEMBL3535063 0.83 BRAF (0.59) EGFRAURKARPS6KB1LRRK2KDR
SCHEMBL7022596 0.83 BRAF (0.60) EGFRAURKARPS6KB1LRRK2KDR
SCHEMBL7019299 0.83 EGFR (0.51) EGFRAURKARPS6KB1LRRK2KDR
Hydrochloric Acid SCHEMBL7017702 0.82 BRAF (0.59) EGFRAURKARPS6KB1LRRK2KDR
SCHEMBL7016715 0.81 EGFR (0.48) EGFRAURKARPS6KB1LRRK2KDR
SCHEMBL7025011 0.80 AURKA (0.56) EGFRAURKARPS6KB1KDRGAK
SCHEMBL7661400 0.79 BRAF (0.50) EGFRAURKARPS6KB1KDRGAK
SCHEMBL7668798 0.78 BRAF (0.53) EGFRLRRK2GAKFBP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831829-B1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER (US) 2003-08-20 EP claimed
JP-3290666-B2 2002-06-10 JP claimed
US-6395733-B1 ANTICANCER AGENTS; ANTIPROLIFERATIVE AGENTS PFIZER INC 2002-05-28 US claimed
EP-0831829-A4 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER (US) 1998-11-25 EP claimed
EP-0831829-A1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER INC. (US) 1998-04-01 EP claimed
CN-1141298-A Pyrimidine-fused heterocyclic compound anti-cancer agents PFIZER (US) 1997-01-29 CN claimed
WO-1996040142-A1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER INC. (US) 1996-12-19 WO claimed
EP-0831829-B1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER (US) 2003-08-20 EP disclosed
US-6395733-B1 ANTICANCER AGENTS; ANTIPROLIFERATIVE AGENTS PFIZER INC 2002-05-28 US disclosed
EP-0831829-A4 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER (US) 1998-11-25 EP disclosed
EP-0831829-A1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER INC. (US) 1998-04-01 EP disclosed
CN-1141298-A Pyrimidine-fused heterocyclic compound anti-cancer agents PFIZER (US) 1997-01-29 CN disclosed
WO-1996040142-A1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER INC. (US) 1996-12-19 WO disclosed